Andere talen Otsuka Holdings Co., Ltd.

Aandelen

4578

JP3188220002

Farmaceutische producten

Vertraagde tijd Japan Exchange Andere beurzen 06:06:00 16-01-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
8.053,00 ^JPY	-0,12%		-4,28%	-6,35%

14/01	Otsuka zegt dat de Amerikaanse FDA een adviesbijeenkomst houdt voor een combinatie van PTSS-behandelingen	MT
27/11	Otsuka rondt aandeleninkoopprogramma af	MT

Andere talen

Otsuka Says US FDA to Hold Advisory Meeting for PTSD Treatment Combo	14/01
Otsuka Completes Share Repurchase Program	27/11
Tranche Update on Otsuka Holdings Co., Ltd.'s Equity Buyback Plan announced on August 1, 2024.	26/11
Otsuka Holdings Co., Ltd.'s Equity Buyback announced on August 1, 2024 has closed with 5,810,900 shares, representing 1.07% for ¥49,882.99 million.	22/11
Nikkei Slips as Beijing's Property Support Measures Fail to Lift Sentiment	14/11
Otsuka, ICU Medical Launch Joint Venture in North America	14/11
Otsuka : Message from Tatsuo Higuchi, President and Representative Director, CEO	31-10-24
Otsuka : Message from Makoto Inoue, Representative Director, COO	31-10-24
Otsuka Holdings Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. Announces Changes of Representative Director	31-10-24
Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024	31-10-24
Otsuka Holdings Co., Ltd. Announces CEO Changes	31-10-24
Otsuka Holdings Reports Phase 3 Trial Results for Sibeprenlimab in IgA Nephropathy	23-10-24
IRLAB Therapeutics AB Announces Positive Data from the First Part of Phase I Study with the Drug Candidate IRL 757	03-10-24
Tranche Update on Otsuka Holdings Co., Ltd.'s Equity Buyback Plan announced on August 1, 2024.	01-10-24
Japanese Shares Fall into Red After Four-Day Rally Despite China's Stimulus Package	25-09-24
Otsuka Pharmaceutical Secures Additional Indication for Rexulti in Japan	25-09-24
Otsuka's Profit Up 5% in Fiscal H1	02-08-24
Global markets live: Shell, Chevron, Boeing, Walt Disney, Qualcomm...	01-08-24
Borsa di Italia: a caccia del naturale	01-08-24
Bolsa de Madrid: A la caza de lo natural	01-08-24
Chassez le naturel…	01-08-24
Japan's Otsuka Pharma to pay up to $1.1 bln to acquire Jnana Therapeutics	01-08-24
Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024	01-08-24
Otsuka Holdings Co., Ltd. Announces Second Quarter-End Dividend for the Six Months Ended June 30, 2024, Payable on September 2, 2024	01-08-24
Otsuka Holdings Co., Ltd. announces an Equity Buyback for 10,000,000 shares, representing 1.84% for ¥50,000 million.	01-08-24

Word de lid om toegang te krijgen tot meer nieuws.

Gratis inschrijven

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Otsuka Holdings Co., Ltd.

Aandelen

4578

JP3188220002

Farmaceutische producten

Andere talen

Filters